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Abstract 
We propose a novel computational strategy for de-novo design of molecules with desired properties termed 
ReLeaSE (Reinforcement Learning for Structural Evolution). Based on deep and reinforcement learning 
approaches, ReLeaSE integrates two deep neural networks – generative and predictive – that are trained 
separately but employed jointly to generate novel targeted chemical libraries. ReLeaSE employs simple 
representation of molecules by their SMILES strings only. Generative models are trained with stack-augmented 
memory network to produce chemically feasible SMILES strings, and predictive models are derived to forecast 
the desired properties of the de novo generated compounds. In the first phase of the method, generative and 
predictive models are trained separately with a supervised learning algorithm. In the second phase, both models 
are trained jointly with the reinforcement learning approach to bias the generation of new chemical structures 
towards those with the desired physical and/or biological properties. In the proof-of-concept study, we have 
employed the ReLeaSE method to design chemical libraries with a bias toward structural complexity or biased 
toward compounds with either maximal, minimal, or specific range of physical properties such as melting point 
or hydrophobicity, as well as to develop novel putative inhibitors of JAK2. The approach proposed herein can 
find a general use for generating targeted chemical libraries of novel compounds optimized for either a single 
desired property or multiple properties. 
 
 
Introduction 
The combination of big data and artificial intelligence was referred to by the World Economic Forum as the 
fourth industrial revolution, that can radically transform the practice of scientific discovery (1). Artificial 
intelligence (AI) is revolutionizing medicine (2) including radiology, pathology and other medical specialties 
(3). Deep Learning (DL) technologies are beginning to find applications in drug discovery (4, 5) including areas 
of molecular docking (6) , transcriptomics (7) , reaction mechanism elucidation (8) , and molecular energy 
prediction (9, 10).  
The crucial step in many new drug discovery projects is the formulation of a well-motivated hypothesis for new 
lead compound generation (de novo design) or compound selection from available or synthetically feasible 
chemical libraries based on the available SAR data. The design hypotheses are often biased towards preferred 
chemistry (11) or driven by model interpretation (12). Automated approaches for designing compounds with 
the desired properties de novo have become an active field of research in the last 15 years (13–15). The diversity 
of synthetically feasible chemicals that can be considered as potential drug-like molecules was estimated to be 
between 1030 and 1060 (16). Great advances in computational algorithms (17, 18), hardware, and high-
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throughput screening (HTS) technologies (19) notwithstanding, the size of this virtual library prohibits its 
exhaustive sampling and testing by systematic construction and evaluation of each individual compound. Local 
optimization approaches have been proposed but they do not ensure the optimal solution, as the design process 
converges on a local or ‘practical’ optimum by stochastic sampling, or restricts the search to a defined section 
of chemical space which can be screened exhaustively (13, 20, 21).  
Notably, a method for exploring chemical space based on continuous encodings of molecules was proposed 
recently (22). It allows efficient, directed gradient-based search through chemical space but does not include 
biasing libraries toward special physical or biological properties. Another very recent approach for generating 
focused molecular libraries with the desired bioactivity using Recurrent Neural Networks was proposed as well 
(23). However, properties of produced molecules could not be controlled well. Adversarial autoencoder was 
proposed recently (24) as a tool for generating new molecules with the desired properties; however, compounds 
of interest are selected by the means of virtual screening of large libraries, not by designing novel molecules. 
Specifically, in this method, points from the latent space of chemical descriptors are projected to the nearest 
known molecule in the screening database. 
Herein, we propose a novel method for generating chemical compounds with desired physical, chemical and/or 
bioactivity properties de novo that is based on deep reinforcement learning (RL). Reinforcement learning is a 
subfield of artificial intelligence, which is used to solve dynamic decision problems. It involves the analysis of 
possible actions and estimation of the statistical relationship between the actions and their possible outcomes, 
followed by the determination of a treatment regime that attempts to find the most desirable outcome. The 
integration of reinforcement learning and neural networks dates back to 1990s (25). However, with the recent 
advancement of deep learning (DL), benefiting from Big Data, new powerful algorithmic approaches are 
emerging. There is a current renaissance of RL (26), especially when it is combined with deep neural networks, 
i.e., deep reinforcement learning. Most recently, RL was employed to achieve superhuman performance in the 
game Go (27), considered practically intractable due to the theoretical complexity of over 10140 possible 
solutions (28). One may see an analogy with the complexity of chemical space exploration with an algorithm 
that avoids brute-force computing to examine every possible solution. Below we describe the application of 
deep RL to the problem of designing chemical libraries with the desired properties and show that our approach 
termed ReLeaSE affords plausible solution of this problem.   
The proposed ReLeaSE approach alleviates the deficiency of a small group of methodologically similar 
approaches discussed above. The most distinct innovative aspects of the approach proposed herein include the 
simple representation of molecules by their SMILES strings only for both generative and predictive phases of 
the method and integration of these phases into a single workflow including RL module. We demonstrate that 
ReLeaSE enables the design of chemical libraries with the desired physico-chemical and biological properties. 
Below we discuss both the algorithm and its proof-of-concept applications to designing targeted chemical 
libraries. 
 
Results 
We have devised a novel RL-based method termed ReLeaSE (Reinforcement Learning for Structural Evolution) 
for generating new chemical compounds with desired physical, chemical or bioactivity properties. The general 
workflow for the ReLeaSE method (Figure 1) includes two deep neural networks (generative G and predictive 
                                                                                           Page 3 of 28 
 
P). The process of training consists of two stages. During the first stage, both models are trained separately with 
supervised learning algorithms, and during the second stage, the models are trained jointly with a reinforcement 
learning approach that optimizes target properties. In this system, the generative model is used to produce novel 
chemically feasible molecules, i.e.,  it plays a role of an agent whereas the predictive model (that predicts 
properties of novel compounds) plays the role of a critic, which estimates the agent's behavior by assigning a 
numerical reward (or penalty) to every generated molecule. The reward is a function of the numerical property 
generated by the predictive model, and the generative model is trained to maximize the expected reward. 
Reinforcement learning formulation as applied to chemical library design. Both generative (G) and 
predictive (P) models are combined into a single RL system. The set of actions A is defined as an alphabet, i.e., 
the entire collection of letters and symbols is used to define canonical SMILES strings that are most commonly 
employed to encode chemical structures. For example, an aspirin molecule is encoded as 
[CC(=O)OC1=CC=CC=C1C(=O)O]. The set of states S is defined as all possible strings in the alphabet with 
lengths from zero to some value T. The state 𝑠"	with length 0 is unique and considered the initial state. The state 𝑠$ of length T is called the terminal state, as it causes training to end. The subset of terminal states 𝑆∗ = 	 {𝑠𝑇 ∊ 𝑆} 
of S, which contains all states 𝑠𝑇 with length T is called the terminal states set. Reward 𝑟(𝑠$) is calculated at the 
end of the training cycle when the terminal state is reached. Intermediate rewards 𝑟(𝑠/), 𝑡 < 𝑇  are equal to zero. 
In these terms, the generative network G can be treated as a policy approximation model. At each time step t, 0 
< t < T, G takes the previous state 𝑠𝑡−1 as an input and estimates probability distribution 𝑝(𝑎/	|	𝑠/89)  of the next 
action. Afterwards, the next action 𝑎𝑡 is sampled from this estimated probability. Reward 𝑟(𝑠$) is a function of 
the predicted property of 𝑠𝑇 using the predictive model P: 𝑟(𝑠$) = 𝑓;𝑃(𝑠$)= (1) 
where f is chosen depending on the task. Some examples of the functions f are provided in the computational 
experiment section. Given these notations and assumptions, the problem of generating chemical compounds 
with desired properties can be formulated as a task of finding a vector of parameters Θ of policy network G 
which maximizes the expected reward: 
𝐽(𝛩) = 	𝔼[𝑟(𝑠$)	|	𝑠", 𝛩] = 	 C 𝑝D(𝑠$)𝑟(𝑠$) 	→ 𝑚𝑎𝑥.IJ	∊	K∗  (2) 
This sum iterates over the set 𝑆∗ of terminal states. In our case, this set is exponential and the sum cannot be 
computed exactly. According to the law of large numbers, we can approximate this sum as a mathematical 
expectation by sampling terminal sequences from the model distribution: 𝐽(𝛩) = 	𝔼[𝑟(𝑠$)	|	𝑠", 𝛩] = 	𝔼LM~OP(LM	|	IQ)	𝔼LR~OP(LR	|	IM) …𝔼LJ~OP(LJ	|	IJTM)𝑟(𝑠$).		 (3) 
To estimate J(Θ), we sequentially sample 𝑎𝑡 from the model G for t from 0 to T. The unbiased estimation for 
J(Θ) is the sum of all rewards in every time step, which, in our case, equals the reward for the terminal state as 
we assume that intermediate rewards are equal to 0. This quantity needs to be maximized; therefore, we need 
to compute its gradient. This can be done, for example, with the REINFORCE algorithm (29) that uses the 
approximation of mathematical expectation as a sum, which we provided in equation 3, and the following form: 
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𝜕𝛩𝑓(𝛩) = 𝑓(𝛩) 𝜕𝛩𝑓(𝛩)𝜕𝛩 = 𝑓(𝛩)𝜕𝛩 log 𝑓(𝛩). (4) 
Therefore, the gradient of J(Θ) can be written down as: 
𝜕𝛩𝐽(𝛩) 	= 	 CY𝜕𝛩𝑝𝛩(𝑠𝑇)Z𝑟(𝑠𝑇) =𝑠𝑇∊𝑆∗ C 𝑝𝛩(𝑠𝑇)Y𝜕𝛩 log 𝑝𝛩(𝑠𝑇)Z𝑟(𝑠𝑇)𝑠𝑇∊𝑆∗
= C 𝑝𝛩(𝑠𝑇) [C𝜕𝛩 log 𝑝𝛩(𝑎𝑡|𝑠𝑡−1)𝑇𝑡=1 \ 𝑟(𝑠𝑇)𝑠𝑇∊𝑆∗
= 𝔼𝑎1~𝑝𝛩(𝑎1|𝑠0)𝔼𝑎2~𝑝𝛩(𝑎2|𝑠1) … 𝔼𝑎𝑇~𝑝𝛩(𝑎𝑇|𝑠𝑇−1) [C𝜕𝛩 log 𝑝𝛩(𝑎𝑡|𝑠𝑡−1)𝑇𝑡=1 \ 𝑟(𝑠𝑇), 
(5) 
which gives an algorithm 𝜕𝛩𝐽(𝛩) estimation. 
Neural networks architectures. Model G (Figure 1A) is a generative recurrent neural network, which outputs 
molecules in SMILES notation. We use a special type stack-augmented recurrent neural network (Stack-RNN) 
(30) that has found success in inferring algorithmic patterns. In our implementation, we consider legitimate (i.e., 
corresponding to chemically feasible molecules) SMILES strings as sentences composed of characters used in 
SMILES notation. The objective of Stack-RNN then is to learn hidden rules of forming sequences of letters that 
correspond to legitimate SMILES strings. 
To generate a valid SMILES string, in addition to correct valence for all atoms, one must count, ring opening 
and closure, as well as bracket sequences with several bracket types. Regular recurrent neural networks like 
LSTM (31) and GRU (32) are unable to solve the sequence  
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Figure 1. The workflow implementingdDeep RL algorithm for generating new SMILES strings of 
compounds with the desired properties. A. Training step of the generative stack-augmented RNN; B. 
Generator step of the generative stack-augmented RNN. During training, the input token is a character in the 
currently processed SMILES string from the training set. The model outputs the probability vector 𝑝D(𝑎/|𝑠/89) 
of the next character given a prefix. Vector of parameters 𝛩 is optimized by cross-entropy loss function 
minimization. In the generator regime, the input token is a previously generated character. Next, character 𝑎/ is 
sampled randomly from the distribution 𝑝D(𝑎/|𝑠/89). C. General pipeline of reinforcement learning system for 
novel compounds generation. D. Scheme of predictive model. This model takes a SMILES string as an input 
and provides one real number, which is an estimated property value, as an output. Parameters of the model are 
trained by 𝑙` squared loss function minimization. 
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prediction problems due to their inability to count. One of the classical examples of sequences that cannot be 
properly modeled by regular recurrent networks are words from the Dyck language, where all open square 
brackets are matched with the respective closed ones (33). Formal language theory states that context-free 
languages, such as Dyck language, can not be generated by model without stack memory (34). As valid SMILES 
string should at least be a sequence of all properly matched parentheses with multiple types of brackets, 
recurrent neural networks with an additional memory stack is a theoretically justified choice for modelling 
SMILES. Another weakness of regular recurrent neural networks is their inability to capture long term 
dependencies, which leads to difficulties in generalizing to longer sequences (35). All of these features are 
required to learn the language of the SMILES notation. In a valid SMILES molecule, in addition to correct 
valence for all atoms, one must count, ring opening and closure, as well as bracket sequences with several 
bracket types. Therefore, only memory-augmented neural networks like Stack-RNN or Neural Turing Machines 
are the appropriate choice for modeling such sequence dependencies. 
The Stack-RNN defines a new neuron or cell structure on top of the standard GRU cell (see Figure 1A). It has 
two additional multiplicative gates referred to as the memory stack, which allow the Stack-RNN to learn 
meaningful long-range interdependencies. Stack is a differentiable structure onto and from which continuous 
vectors are inserted and removed. In stack terminology, the insertion operation is called PUSH operation and 
the removal operation is called POP operation. These traditionally discrete operations are continuous here, since 
PUSH and POP operations are permitted to be real values in the interval (0, 1). Intuitively, we can interpret 
these values as the degree of certainty with which some controller wishes to PUSH a vector v onto the stack, or 
POP the top of the stack. Such an architecture resembles a pushdown automata, which is a classic framework 
from the theory of formal languages capable of dealing with more complicated languages. Applying this concept 
to neural networks provides the possibility to build a trainable model of the language of SMILES with correct 
syntaxes, proper balance of ring-opening and closures and correct valences for all elements.  
The second model P is a predictive model (see Figure 1D) for estimating physical, chemical or biological 
properties of molecules. This property prediction model is a deep neural network, which consists of an 
embedding layer, LSTM layer and two dense layers. This network is designed to calculate user-specified 
property (activity) of the molecule taking SMILES string as an input data vector. In a practical sense, this 
learning step is analogous to traditional Quantitative Structure-Activity Relationships (QSAR) models. 
However, unlike conventional QSAR, no numerical descriptors are needed, as the model distinctly learns 
directly from the SMILES notation as to how to relate the comparison between SMILES strings to that between 
target properties. 
Generation of chemicals with novel structures. The generative network was trained with ~1.5M structures 
from ChEMBL21 database (36) (please see Methods for technical details); the objective of training was to learn 
rules of organic chemistry that define SMILES string corresponding to realistic chemical structures. To 
demonstrate the versatility of the baseline (unbiased) Stack-RNN, we generated over one million (1M) of 
compounds. All structures are available for download from Supplementary Information. Random examples of 
the generated compounds are illustrated in Figure 2. 
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Figure 2. A sample of molecules produced by the generative model. 
A known deficiency of approaches for de novo molecular design is frequent generation of chemically infeasible 
molecules.(22, 37) To address this possible issue of concern, we have established that 95% of all generated 
structures, were valid, chemically sensible, molecules. The validity check was performed by the structure 
checker from ChemAxon (38). We compared the 1M de novo generated molecules with those used to train the 
generative model from the ChEMBL database and found that the model produced less than 0.1% of structures 
from the training dataset. Additional comparison with the ZINC15 database (39) of 320M synthetically 
accessible drug-like molecules showed that about 3% (~32,000 molecules) of de novo generated structures could 
be found in ZINC. All ZINC IDs for the matching molecules are available in the Supplementary Information.  
To assess the importance of using stack memory augmented network as described in Methods, we compared 
several characteristics of chemical libraries generated by models developed either with or without stack 
memory. For this purpose, we trained another generative recurrent neural network with the same architecture 
but without using stack memory. Libraries were compared by the percentage of valid generated SMILES, 
internal diversity, and similarity of the generated molecules to those in the training dataset (ChEMBL). The 
model without stack memory showed that only 86% of molecules in the respective library were valid (as 
evaluated by ChemAxon, cf. Methods) compared to 95% of valid molecules in the library generated with stack 
memory network. As expected (cf. the justification for using stack memory augmented network in Methods), 
in the former library, syntactic errors such as open brackets, unclosed cycles and incorrect bond types in 
SMILES strings were more frequent. Based on the analysis of respective sets of 10000 molecules generated by 
each method (See Figure 3A), the library obtained without stack memory showed a decrease of the internal 
diversity by 0.2 units of the Tanimoto coefficient and yet, a four-fold increase in the number of duplicates, from 
just about 1% to 5%. In addition, Figure 3B shows that the number of molecules similar to the training dataset 
(Ts > 0.85) for library obtained without stack memory (28% of all molecules) is twice that obtained with stack 
memory (14%). These results clearly highlight the advantages of using neural network with memory for 
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generating the highest number of realistic and predominantly novel molecules, which is one of the chief 
objectives of de novo chemical design. 
  
 
Figure 3. Performance of the generative model G, with and without stack-augmented memory. (A) 
Internal diversity of generated libraries; (B) Similarity of the generated libraries to the training dataset from the 
ChEMBL database. 
In order to further characterize the structural novelty of the de novo generated molecules, we compared the 
content of the Murcko scaffolds (40) between the ChEMBL training set and the virtual library generated by our 
system. Murcko scaffolds provide a hierarchical molecular organization scheme by dividing small molecules 
into R-groups, linkers, and frameworks, or scaffolds. They define the ring systems of a molecule by removing 
side chain atoms. We found that less than 10% of scaffolds in our library were present in ChEMBL. Overall, 
this analysis suggests that generative Stack-RNN model did not simply memorize the training SMILES 
sequences but was indeed capable of generating extremely diverse yet realistic molecules as defined by the 
structure checker from ChemAxon. 
In addition to passing the structure checker, an important requirement for de novo generated molecules is their 
synthetic feasibility. To this end, we employed the synthetic accessibility score (SAS) method (41), which relies 
on the knowledge extracted from known synthetic reactions and adds penalty for high molecular complexity. 
For ease of interpretation, SAS is scaled to be between 1 and 10. Molecules with the high SAS value, typically 
above 6 are considered difficult to synthesize, whereas, molecules with the low SAS values are easily 
synthetically accessible. The distribution of SAS values calculated for 1M molecules generated by the ReLeaSE 
is shown in Supplementary Figure S1. To illustrate the robustness of the de novo generated chemical library, 
we compared its SAS distribution with that of the SAS values both for the full ChEMBL library (~1.5M 
molecules) and for 1M random sample of molecules in ZINC. Similar to typical commercial vendor libraries, 
distribution of SAS for ReLeaSE is skewed towards more easily synthesizable molecules. Median SAS values 
were 2.9 for ChEMBL and 3.1 for both ZINC and ReLeaSE. Over 99.5% of de novo generated molecules had 
SAS values below 6. Therefore, despite their high novelty, vast majority of generated compounds can be 
considered as synthetically accessible. 
Property prediction. Over more than 50 years of active development of the field, well-defined QSAR protocols 
and procedures have been established (42), including best practices for model validation as reported in several 
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highly cited papers by our group (42, 43). Any QSAR method can be generally defined as an application of 
machine learning and/or statistical methods to the problem of finding empirical relationships of the form y = 
ƒ(X1, X2,…,Xn), where y is biological activity (or any property of interest) of molecules; X1, X2,…, Xn are 
calculated molecular descriptors of compounds; and, ƒ is some empirically established mathematical 
transformation that should be applied to descriptors to calculate the property values for all molecules. Model 
validation is a critical component of model development; our approach to model validation in this study is 
described in Methods. 
Building machine learning (ML) models directly from SMILES strings, which is a unique feature of our 
approach, completely bypasses the most traditional step of descriptor generation in QSAR modeling. In addition 
to being relatively slow, descriptor generation is non-differentiable and it does not allow a straightforward 
inverse mapping from the descriptor space back to molecules albeit a few approaches for such mapping (i.e., 
inverse-QSAR) have been proposed (44–46). For instance, one of the studies described above (22) used 
mapping from the point in latent variable to real molecules represented by points most proximal to that point. 
In contrast, using neural networks directly on SMILES is fully differentiable, and it also enables direct mapping 
of properties to the SMILES sequence of characters (or strings). SMILES strings were used for QSAR model 
building previously (47, 48); however, in most cases SMILES strings were used to derive string- and substring-
based numerical descriptors (49). Note that, in our case, the ability to develop QSAR models using SMILES 
was critical for integrating property assessment (evaluative models) and de novo structure generation 
(generative models) into a single RL workflow as described below. 
In terms of external prediction accuracy, SMILES based ML models also performed very well. For example, 
using five-fold cross validation we obtained the external model accuracy expressed as R2ext of 0.91 and RMSE 
= 0.53 for predicting LogP (See Methods section). This compared favorably to a Random Forest model with 
DRAGON7 descriptors (R2ext = 0.90 and RMSE = 0.57). For the melting temperature prediction, the observed 
RMSE of 35 oC was the same as that predicted with the state-of-the-art consensus model obtained by using an 
ensemble of multiple conventional descriptor-based ML models (50), which afforded RMSE of 35 oC.   
The following study was undertaken to evaluate the external predictive accuracy for novel compounds designed 
with the ReLeaSE method. We have identified over 100 compounds from our library in the ChEMBL database 
that were not present in the training set. Then we manually extracted their experimental LogP or Tmelt data 
from as recorded in PubChem database. Multiple measurements were averaged. Final subsets were comprised 
from about 20 molecules for each property. The comparison between predicted and experimental measurements 
yielded RMSE of 0.9 for LogP and ~42 degrees for Tmelt. This accuracy was slightly lower than that for the 
respective QSPR model obtained with cross-validation. We consider the reasonable success of this exercise in 
property prediction for an external dataset as an additional evidence that our approach yields molecules with 
both desired and accurately predicted properties 
Generation of property value biased libraries with the RL system. To explore the utility of the RL algorithm 
in a drug design setting, we have conducted case studies to design libraries with three controlled target 
properties: a) physical properties considered important for drug-like molecules, b) specific biological activity, 
and c) chemical complexity. For physical properties, we selected melting temperature (Tm) and n-octanol/ water 
partition coefficient (LogP). For bioactivity prediction, we designed putative inhibitors of Janus protein kinase 
2 (JAK2) with novel chemotypes. Finally, the number of benzene rings and the number of substituents (like –
OH, -NH2, -CH3 –CN, etc.) was used as a structural reward to design novel chemically complex compounds. 
Figure 4 shows the distribution of predicted properties of interest in the training test molecules and in the 
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libraries designed by our system. In all cases, we sampled 10,000 molecules by the baseline (no RL) generator 
and RL-optimized generative models, and then calculated their properties with a corresponding predictive 
model. Values of the substructural features were calculated directly from the 2D structure. Table 1 summarizes 
the analysis of generated molecules and the respective statistics. 
 
Figure 4. Property distributions for RL optimized versus baseline generator model. (A) Melting 
temperature; (B) JAK2 inhibition; (C) Partition coefficient; (D) Number of benzene rings; (E) Number of 
substituents. 
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Melting temperature (Tm). In this experiment, we set two goals, i.e., either to minimize or to maximize the target 
property. Upon minimization, the mean of the distribution in the de novo generated library was shifted by 44 
oC as compared to the training set distribution (Figure 4A). The library of virtually synthesized chemicals 
included simple hydrocarbons like butane, as well as poly-halogenated compounds like CF2Cl2 and C6H4F2. 
The molecule with the lowest Tm=-184 °C in the produced dataset was CF4. Clearly, this property minimization 
strategy was extremely effective, as it allowed for the discovery of molecules in the regions of the chemical 
space far beyond those of the training set of drug-like compounds. In the maximization regime, the mean of the 
melting temperature was increased by 20 °C to 200 °C. As expected, the generated library indeed included 
substantially more complex molecules with the abundance of sulphur-containing heterocycles, phosphates, and 
conjugated double bond moieties. 
Designing a chemical library biased toward a range of lipophilicity (LogP). Compound hydrophobicity is an 
important consideration in drug design. One of the components of the famous Lipinski’s rule of five is that 
orally bioavailable compounds should have their octanol-water partition coefficient LogP less than 5 (51). Thus, 
we endeavored to design a library that would contain compounds with LogP values within a favorable drug-
like range. The reward function in this case was defined as a piecewise linear function of LogP with a constant 
region from 1.0 to 4.0 (see Supplementary Figure S2). In other words, we set the goal to generate molecules 
according to a typical Lipinski’s constraint. As is shown in Figure 4C, we have succeeded in generating a library 
with 88% of the molecules falling within the drug-like region of LogP values. 
Inhibition of JAK2. In the third experiment, which serves as an example of the most common application of 
computational modeling in drug discovery, we have employed our system to design molecules with the specific 
biological function, i.e., JAK2 activity modulation. Specifically, we designed libraries with the goal of 
minimizing or maximizing pIC50 values for JAK2. While most of drug discovery studies are oriented toward 
finding molecules with heightened activity, bioactivity minimization is also pursued in drug discovery to 
mitigate off-target effects.  Therefore, we were interested in exploring the ability of our system to bias the design 
of novel molecular structures toward any desired range of the target properties. JAK2 is non-receptor tyrosine 
kinase involved in various processes such as cell growth, development, differentiation or histone modifications. 
It mediates essential signaling events in both innate and adaptive immunity. In the cytoplasm it also plays an 
important role in signal transduction. Mutations in JAK2 have been implicated in multiple conditions like 
thrombocythemia, myelofibrosis or myeloproliferative disorders (52).  
The reward functions in both cases (min and max) were defined as exponential functions of pIC50 (see 
Supplementary Figure S2). The results of library optimization are shown in Figure 4B. With minimization, the 
mean of predicted pIC50 distribution was shifted by about one pIC50 unit and the distribution was heavily biased 
toward the lower ranges of bioactivity with 24% of molecules predicted to have practically no activity (pIC50 ≤ 
4). In the activity maximization exercise, properties of generated molecules were more tightly distributed across 
the predicted activity range. In each case, our system virtually synthesized both known and novel compounds, 
with the majority of de novo designed molecules being novel compounds. The generation of known compounds 
(i.e. not included in the training set) can be regarded as model validation. Indeed, the system retrospectively 
discovered 793 commercially available compounds deposited in the ZINC database, which constituted about 
5% of the total generated library. Importantly, as many as 15 of them (exemplified by ZINC263823677 -
http://zinc15.docking.org/substances/ZINC000263823677/ and ZINC271402431 - 
http://zinc15.docking.org/substances/ZINC000271402431/) were actually annotated as possible tyrosine kinase 
inhibitors. 
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Substructure bias. Finally, we also performed two simple experiments mimicking the strategy of biased 
chemical library design where the designed library is enriched with certain user-defined substructures. We 
defined the reward function as the exponent of (i) the number of benzene rings (-Ph) and (ii) total number of 
small group substituents. Among all case studies described, structure bias was found to be the easiest to 
optimize. The results of the library optimization study are shown in Figures 4 D, E. Furthermore, Figure 5 
illustrates the evolution of generated structures as the structural reward increases. Indeed, we see that the model 
progresses toward generating increasingly more complex, yet realistic molecules with greater numbers of rings 
and/or substituents.  
 
 
Figure 5. Evolution of generated structures as chemical substructure reward increases. (A) Reward 
proportional to the total number of small group substituents (B) Reward proportional to the number of benzene 
rings. 
We expect that designing structurally biased libraries may be a highly desirable application of the ReLeaSE 
approach as researchers often wish to generate libraries enriched for certain privileged scaffold(-s) and lead 
compounds optimization (53). Conversely, the system also allows to avoid particular chemical groups or 
substructures (like bromine or carboxyl group) that may lead to undesired compound properties such as toxicity. 
Finally, one could implement certain substructure, or pharmacophore similarity, reward to explore additional 
chemical space. 
Table 1 shows a decrease in the proportion of the valid molecules after the optimization. We may explain this 
phenomenon by the weaknesses of predictive models P (See Figure 1C) and the integration of predictive and 
generative models into a single design system. We presume that the generative model G tends to find some 
local optima of the reward function that correspond to invalid molecules, but predictive model P assigns high 
rewards to these molecules. This explanation is also supported by the results of structure bias optimization 
Reward increase
A
B
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experiments, as we did not use any predictive models in these experiments and the decrease in the proportion 
of valid molecules was insignificant. We also noticed, that among all experiments with predictive models, those 
with LogP optimization showed the highest proportion of valid molecules and, at the same time, the predictive 
model for LogP estimation had the highest accuracy R2 = 0.91 (see Methods). Probably it is harder for RL 
system to exploit high quality predictive model P and produce fictitious SMILES strings with predicted 
properties in the desired region. 
Table 1. Comparison of statistics for generated molecular datasets 
Property 
Valid 
molecules
, % 
Mean 
SA 
score 
Mean 
molar 
mass 
Mean 
value of 
target 
property 
Match with 
ZINC15 
database, % 
Match with  
ChEMBL 
database, %  
Melting 
temperature 
baseline 95 3.1 435.4 181 4.7 1.5 
minimized 31 3.1 279.6 137 4.6 1.6 
maximized 53 3.4 413.2  200 2.4 0.9 
pIC50 for 
JAK2 
baseline 95 3.1 435.4 5.70 4.7 1.5 
minimized 60 3.85 481.8 4.89 2.5 1.0 
maximized 45 3.7 275.4 7.85 4.5 1.8 
log P 
baseline 95 3.1 435.4 3.63 4.7 1.5 
range opt. 70 3.2 369.7 2.58 5.8 1.8 
Number of 
benzene 
rings 
baseline 95 3.1 435.4 0.59 4.7 1.5 
maximized 83 3.15 496.0 2.41 5.5 1.6 
Number of 
substituents 
baseline 95 3.1 435.4 3.8 4.7 1.5 
maximized 80 3.5 471.7 7.93 3.1 0.7 
Model analysis. Model interpretation is a highly significant component in any ML study. In this section we 
demonstrate how Stack-RNN learns and memorizes useful information from the SMILES string as it is being 
processed. More specifically, we have manually analyzed neuron gate activations of the neural network as it 
processes the input data.  
Figure 6 lists several examples of cells in neural networks with interpretable gate activations. In this figure, 
each line corresponds to activations of a specific neuron at different SMILES processing time steps by the pre-
trained baseline generative model. Each letter is colored according to the value of tanh activation in a cool-
warm colormap from dark blue to dark red, i.e., from -1 to 1. We found that our RNN has several interpretable 
cells. These cells can be divided into two groups – chemically sensible groups, which activate in the presence 
of specific chemical groups or moieties, and syntactic groups, which keep tracks of numbers, bracket opening 
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and closure, and even of SMILES string termination when the new molecule is generated. For instance, we saw 
cells reflecting the presence of a carbonyl group, aromatic groups or NH moieties in heterocycles. We also 
observed that in two of these three examples there were counter-cells that deactivate in the presence of the 
aforementioned chemical groups. Neural network-based models are notoriously uninterpretable (54) and the 
majority of cells were indeed in that category. On the other hand, the possibility of even partial interpretation 
offered by this approach could be highly valuable for a medicinal chemist. 
 
Figure 6. Examples of Stack-RNN cells with interpretable gate activations. Color coding corresponds to 
GRU cells with hyperbolic tangent 𝑡𝑎𝑛ℎ activation function, where dark blue corresponds to the activation 
function value of -1 is and red described the value of the activation function of 1; the numbers in the range 
between -1 and 1 are colored using cool-warm color map. 
Visualization of new chemical libraries. In order to understand how the generative models populate chemical 
space with new molecules, we used t-Distributed Stochastic Neighbor Embedding (t-SNE) for dimensionality 
reduction (55). We selected datasets for three endpoints used in our case studies (Tm, LogP, JAK2) that were 
produced with corresponding optimized generative models G. For every molecule, we calculated a latent vector 
of representation from the feed-forward layer with ReLU activation function in the predictive model P for the 
respective property and constructed 2D projection using t-SNE. These projections are illustrated in Figure 7. 
Every point corresponds to a molecule and is colored according to its property value.  
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Figure 7. Clustering of generated molecules by t-distributed stochastic neighbor embedding (t-SNE). 
Molecules are colored based on the predicted properties by the predictive model 𝑃, with values shown by the 
color bar on the right. (A, C) Examples of the generated molecules are randomly picked from matches with 
ZINC database, property values predicted by the predictive model P. (A) Partition coefficient, logP (B) Melting 
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temperature, Tm oC; examples show generated molecules with lowest and highest predicted melting 
temperatures; (C) JAK2 inhibition, predicted pIC50. 
For libraries generated to achieve certain partition coefficient distribution (Figure 7A), we can observe well-
defined clustering of molecules with similar LogP values. In contrast, for melting temperature (Figure 7B) there 
are no such clusters. High and low Tm molecules are intermixed together. This observation can be explained by 
the fact, that melting temperature depends not only on the chemical structure of the molecule, but also on 
intermolecular forces as well as packing in the crystal lattice. Therefore, plotting molecules in this neural net 
representation could not achieve good separation of high vs. low Tm. In the case of the JAK2 model, we could 
observe two large non-overlapping areas roughly corresponding to inactive (pIC50<6) and active(pIC50≥6) 
compounds. Inside these areas, molecules are typically clustered around multiple privileged scaffolds. 
Specifically for JAK2 we see abundance of compounds with 1,3,5-triazine, 1,2,4-triazine, 5-Methyl-1H-1,2,4-
triazole, 7H-pyrrolo[2,3-d]pyrimidine, 1H-pyrazolo[3,4-d]pyrimidine, thieno-triazolo-pyrimidine and other 
substructures. Overall, this approach offers a rapid way to visualize compound distribution in chemical space 
in terms of both chemical diversity and variability in the values of the specific prediction endpoint. Furthermore, 
joint embedding of both molecules in the training set and those generated de novo allows one to explore 
differences in the chemical space coverage by both sets and establish whether structurally novel compounds 
also have the desired predicted property of interest.  
Discussion 
We have created and implemented a deep reinforcement learning approach termed ReLeaSE for de novo design 
of novel chemical compounds with desired properties. To achieve this outcome, two deep neural networks – 
generative and predictive were combined in a general workflow that also included the RL step (Figure 1). The 
training process consists of two stages. In the first stage, both models are trained separately using supervised 
learning, and in the second stage, models are trained jointly with a reinforcement learning method. Both neural 
networks employ end-to-end deep learning.  The ReLeaSe method does not rely on pre-defined chemical 
descriptors; the models are trained on chemical structures represented by SMILES strings only. This distinction 
makes this approach clearly differentiated from traditional QSAR methods and simpler both to use and execute.  
This method needs to be evaluated in the context of several previous and parallel developments elsewhere to 
highlight its unique innovative features. Our ReLeaSE method has benefited from the recent developments in 
the machine learning community as applied to natural language processing and machine translation. These new 
algorithms allow learning the mapping from an input sequence (e.g., a sentence in one language) to an output 
sequence (that same sentence in another language). The entire input sentence represents an input vector for the 
neural network. The advantage of this approach is that it requires no handcrafted feature engineering. 
Considering the use of similar approaches in chemistry, several comparable developments elsewhere should be 
discussed. Reinforcement Learning approach for de-novo molecular design was introduced in reference (37) as 
well. However, no data was provided to show that the predicted properties of molecular compounds are 
optimized. Instead of demonstrating the shift in distribution of biological activity values against dopamine 
receptor type 2 (DRD2) before and after the optimization, that study showed an increase in the fraction of the 
generated molecules, that are similar to training and test sets. This increase does not mean automatically, that 
the generative model is capable of producing novel active compounds. On the contrary, this result may indicate 
a model’s weaknesses in predicting novel valuable chemicals that are merely similar to the training set 
compounds; that is the model is fitted to the training set but may have a limited ability to generate novel 
chemicals that are substantially different from the training set compounds. Indeed, the generative model in 
references (23, 37) is a “vanilla” recurrent neural network without augmented memory stack, which does not 
have the capacity to count and infer algorithmic patterns(34). Another weakness of the approach described in 
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reference (37), from our point of view, is the usage of a predictive model built with numerical molecular 
descriptors, whereas we propose a model, which is essentially descriptor-free and naturally forms a coherent 
workflow together with the generative model. After this manuscript was submitted for publication, a study by 
Jacques et al was published that used simple RNN and off-policy RL to generate molecules.(56) However, in 
addition to low percentage (~30-35%) of valid molecules, in that study, authors did not directly optimize any 
physical or biological properties but rather a proxy function that includes a synthetic accessibility score, drug 
likeness and a ring penalty. 
It is important to highlight the critical element of using QSAR models as part of our approach as opposed to 
traditional use of QSAR models for virtual screening of chemical libraries. The absolute majority of compounds 
generated de novo by the ReLeaSE method are novel structures as compared to the datasets used to train 
generative models, and any QSAR model could be used to evaluate their properties. However, one of our chief 
objectives was to develop a method that can tune not only structural diversity (cf. Case study 1), but most 
importantly, bias the property (physical or biological) toward the desired range of values (case studies 2 and 3). 
The principal element of the ReLeaSE method as compared to traditional QSAR models is that QSAR models 
are implemented within the ReLEeaSE such as to put “pressure” on the generative model. Thus, albeit any 
QSAR model could evaluate properties of new chemicals, those built into our method are used directly for 
reinforcement learning to bias de novo library design toward the desired property. 
As a proof of principle, we tested our approach on three diverse types of endpoints: physical properties, 
biological activity and chemical substructure bias. The use of flexible reward function enables different library 
optimization strategies where one can minimize, maximize or impose a desired range to a property of interest 
in the generated compound libraries. As a by-product of these case studies, we have generated a dataset of over 
1M of novel compounds. In this work we have focused on presenting the new methodology and its application 
for initial hit generation. However, ReLeaSE could also be used for lead optimization, where a particular 
privileged scaffold is fixed and only substituents are optimized. Our future studies will explore this direction. 
Computational library design methods are often criticized for their inability to control synthetic accessibility of 
de novo generated molecules (13). Indeed, computationally generated compounds are often quite complex; for 
instance, they may include exotic substituents. In many cases, such compounds may require multi-step custom 
syntheses or even could be synthetically inaccessible with the current level of technology. In the pharmaceutical 
industry, the ease of synthesis of a prospective hit molecule is of primary concern as it strongly affects the cost 
of the manufacturing process required for the industrial-scale production. For all experiments in this paper, the 
synthetic accessibility of de novo generated focused libraries was estimated using the SAS score (41). 
Distributions of SAS values are shown in Supplementary Figure S3, and the medians of the SAS scored are 
listed in Table 1. This analysis shows clearly that property optimization does not significantly affect synthetic 
accessibility of the generated molecules. The biggest shift of 0.75 for the distribution median was observed in 
the proof-of-concept study targeting the design of JAK2 inhibitors with minimized activity. Less than 0.5% of 
molecules had a high SAS of >6, which is an approximate cutoff for systems that are difficult to synthesize 
(41). 
Obviously, it is technically feasible to include SAS score as an additional reward function; however, in our 
opinion, there are two main reasons as to why this is not desirable, at least with the current form of SAS. First, 
predicted SAS score for newly generated molecules is practically independent of property optimization. Its 
distribution follows that from commercially available compounds. Second, “synthetic accessibility” is not a 
well-defined concept (57). In the process chemistry it depends on multiple factors that determine the ease of 
synthesis of a particular molecule such as the availability of reagents, the number and difficulty of synthetic 
steps, the stability of intermediate products, the ease of their separation, reaction yields, etc (58).  In contrast, 
the most commonly used SAS method (also used in this work) is based on molecular complexity as defined by 
the number of substructures and molecular fragments (41). Therefore, the optimizing SAS score with RL used 
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in our approach will result in substantially reduced novelty of generated molecules and a bias toward 
substructures with low SAS scores used to train the model.  
 
In summary, we have devised and executed a new strategy termed ReLeaSE for designing libraries of 
compounds with the desired properties that employs both deep learning and reinforcement learning approaches. 
In choosing the abbreviation for the name of the method, we were mindful of one of the key meanings of the 
word “release”, i.e., to “allow or enable to escape from confinement; set free”. We have conducted 
computational experiments that demonstrated the efficiency of the proposed ReLeaSE strategy in a single-task 
regime where each of the endpoints of interest is optimized independently. However, this system can be 
extended to afford multi-objective optimization of several target properties concurrently, which is the need of 
drug discovery where the drug molecule should be optimized with respect to potency, selectivity, solubility, 
and ADMET properties. Our future studies will address this challenge. 
 
Materials and Methods 
Experimental Data. The melting point dataset was extracted from the literature (50). The PHYSPROP database 
(https://www.srcinc.com) used to extract the octanol/water partition coefficient, LogP for diverse set of 
molecules. Experimental IC50 and Ki data tested against JAK2 (CHEMBL ID 2971) was extracted from 
ChEMBL (36), PubChem (59) and Eidogen-Sertanty KKB (http://www.eidogen.com). Compounds that had 
inconclusive IC50 values were considered unreliable and were not included in the modeling. 
Data curation. Compiled datasets of compounds were carefully curated following the protocols proposed by 
Fourches et al. (60) Briefly, explicit hydrogens were added, and specifics chemotypes such as aromatic and 
nitro groups were normalized using ChemAxon Standardizer. Polymers, inorganic salts, organometallic 
compounds, mixtures, and duplicates were removed. Modeling-ready curated dataset contained 14,176 
compounds for LogP, 15,549 compounds for JAK2 and 47,425 for melting temperature. All molecules were 
stored as normalized and canonicalized SMILES strings according to procedures developed elsewhere (61). 
Property prediction models. We have built Quantitative Structure-Property Relationship (QSPR) models for 
three different properties – melting temperature, LogP and pIC50 for JAK2. Curated datasets for all three 
endpoints were divided into training and training sets in five-fold cross-validation (5CV) fashion. In developing 
these QSPR models, we followed standard protocols and best practices for QSPR model validation (42). 
Specifically, it has been shown that multiple random splitting of datasets into training and test sets affords 
models of the highest stability and predictive power. Distinctly, models built herein did not use any calculated 
chemical descriptors; rather, SMILES representations were used. Each model consisted of an embedding layer 
transforming the sequence of discrete tokens (i.e., SMILES symbols) into a vector of 100 continuous numbers, 
LSTM layer with 100 units and tanh nonlinearity, one dense layer with 100 units and rectify nonlinearity 
function and one dense layer with one unit and identity activation function. All three models were trained with 
learning rate decay technique until convergence. The resulting 5CV external accuracies of the models are shown 
in Figure S4. 
Training for the generative model. In the first stage, we pre-trained a generative model on a ChEMBL21 (36) 
dataset of approximately 1.5M drug-like compounds, so that the model was capable of producing chemically 
feasible molecules (note that this step does not include any property optimization). This network had 1500 units 
in a recurrent GRU (32) layer and 512 units in a stack augmentation layer. The model was trained on a GPU for 
10000 epochs. The learning curve is illustrated in Figure S5. 
The generative model has two modes of processing sequences – training and generating. At each time step, in 
the training mode, the generative network takes a current prefix of the training object and predicts the probability 
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distribution of the next character. Then, the next character is sampled from this predicted probability distribution 
and is compared to the ground truth. Afterwards, based on this comparison the cross-entropy loss function is 
calculated and parameters of the model are updated. At each time step, in generating mode, the generative 
network takes a prefix of already generated sequences and then, like in the training mode, predicts the 
probability distribution of the next character and samples it from this predicted distribution. In the generative 
model, we do not update the model parameters. 
At the second stage, we combine both generative and predictive model into one reinforcement learning system. 
In this system, the generative model plays the role of an agent, whose action space is represented by the SMILES 
notation alphabet and state space is represented by all possible strings in this alphabet. The predictive model 
plays the role of a critic estimating the agent's behavior by assigning a numerical reward to every generated 
molecule (i.e., SMILES string). The reward is a function of the numerical property calculated by the predictive 
model. At this stage, the generative model is trained to maximize the expected reward. The entire pipeline is 
illustrated in Figure 1. 
We trained a stack-augmented RNN as a generative model. As mentioned above, for training we used the 
ChEMBL database of drug-like compounds.  ChEMBL includes approximately 1.5 million of SMILES strings; 
however, we only selected molecules with the lengths of SMILES string of fewer than 100 characters. The 
length of 100 was chosen because more than 97% of SMILES in training dataset had 100 characters or less (see 
Figure S6). 
Stack-augmented recurrent neural network (30). This section describes generative model G in more details. 
We assume that the data is sequential, which means that it comes in the form of discrete tokens, i.e., characters. 
The goal is to build a model that is able to predict the next token conditioning on all previous tokens. The regular 
recurrent neural network has an input layer and a hidden layer. At time step t neural network takes the 
embedding vector of token number t from the sequence as an input and models the probability distribution of 
the next token given all previous tokens, so that the next token can be sampled from this distribution. 
Information of all previously observed tokens is aggregated in the hidden layer. This can be written down as 
follows: ℎ𝑡 = 𝜎(𝑊𝑖𝑥𝑡 + 𝑊ℎℎ𝑡−1), (6) 
where  ℎ𝑡 is a vector of hidden states, ℎ𝑡−1 – vector of hidden states from the previous time step, 	𝑥𝑡 – input vector at time step t, 𝑊𝑖 – parameters of the input layers, 𝑊ℎ -- parameter of the hidden layer and 𝜎 – 
activation function. 
The stack memory is used to keep the information and deliver it to the hidden layer at the next time step. A 
stack is a type of persistent memory, which can be only accessed through its topmost element. There are three 
operations supported by the stack: POP operation, which deletes an element from the top of the stack, PUSH 
operation, which puts a new element to the top of the stack; and NO-OP operation, which performs no action. 
The top element of the stack has value 𝑠𝑡[0] and is stored at position 0: 𝑠𝑡[0] = 𝑎𝑡[𝑃𝑈𝑆𝐻]𝜎(𝐷ℎ𝑡) + 𝑎𝑡[𝑃𝑂𝑃]𝑠𝑡−1[1] + 𝑎𝑡[𝑁𝑂 − 𝑂𝑃]𝑠𝑡−1[0]. (7) 
where D is 1 ×𝑚 matrix and 𝑎𝑡 = Y𝑎𝑡[𝑃𝑈𝑆𝐻], 𝑎𝑡[𝑃𝑂𝑃], 𝑎𝑡[𝑁𝑂 − 𝑂𝑃]Z is a vector of stack control variables, which 
define the next operation to be performed. If 𝑎𝑡[𝑃𝑂𝑃] is equal to 1, then the value below is used to replace the 
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top element of the stack. If 𝑎𝑡[𝑃𝑈𝑆𝐻] is equal to 1, then a new value will be added to the top and all the rest 
values will be moved down. If 𝑎𝑡[𝑁𝑂 − 𝑂𝑃] equals 1 then stack keeps the same value on top. 
Similar rule is applied to the elements of the stack at a depth i>0: 𝑠𝑡[𝑖] = 𝑎𝑡[𝑃𝑈𝑆𝐻]𝑠𝑡−1[𝑖 − 1] + 𝑎𝑡[𝑃𝑂𝑃]𝑠𝑡−1[𝑖 + 1] + 𝑎𝑡[𝑁𝑂 − 𝑂𝑃]𝑠𝑡−1[𝑖]. (8) 
Now the hidden layer ℎ𝑡 is updated as: ℎ𝑡 = 𝜎(𝑈𝑥𝑡 + 𝑅ℎ𝑡−1 + 𝐷𝑠𝑡−1𝑘 ), (9) 
where D is a matrix of size  𝑚× 𝑘 and 𝑠𝑡−1𝑘  are the first k elements for the top of the stack at time step t-1. 
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Supplementary Materials 
 
 
Figure S1.  Distribution of Synthetic Accessibility Score (SAS) for the full ChEMBL21 database (~1.5M 
molecules), random subsample of 1M molecules from ZINC15 and generated dataset of 1M molecules with 
baseline generator model G. 
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Figure S2. Reward functions. (A) logP optimization (B) pIC50 for JAK2 maximization (C) Melting 
temperature maximization (D) Benzene rings maximization (E) pIC50 for JAK2 minimization (F) Melting 
temperature minimization  (G) Substituent maximization. 
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Figure S3. Distributions of Synthetic Accessibility Score for all RL experiments. (A) Melting 
temperature (B) JAK2 inhibition (C) Partition coefficient (D) Number of benzene rings (E) Number of 
substituents. 
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Figure S4. Distribution of residuals and predicted vs. observed plots for predictive models. 
Results are obtained with external Five-fold Cross-validation. All the values are calculated on hold out 
test datasets (A) Melting temperature (B) logP (C) pIC50 for JAK2. 
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Figure S5. Learning curve for generative model. 
      
  
 Figure S6. Distributions of SMILES’s strings lengths. (A) Initial (B) Truncated. 
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